Is Instil Bio Stock a Good Investment?
Instil Bio Investment Advice | TIL |
- Examine Instil Bio's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Instil Bio's leadership team and their track record. Good management can help Instil Bio navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Instil Bio's business and its evolving consumer preferences.
- Compare Instil Bio's performance and market position to its competitors. Analyze how Instil Bio is positioned in terms of product offerings, innovation, and market share.
- Check if Instil Bio pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Instil Bio's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Instil Bio stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Instil Bio is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Instil Bio Stock
Researching Instil Bio's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 65.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Instil Bio recorded a loss per share of 18.97. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 8th of December 2023.
To determine if Instil Bio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Instil Bio's research are outlined below:
| Instil Bio generated a negative expected return over the last 90 days | |
| Instil Bio has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (156.09 M) with profit before taxes, overhead, and interest of 138 K. | |
| Instil Bio has about 354.61 M in cash with (82.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73. | |
| Instil Bio has a very weak financial position based on the latest SEC disclosures | |
| Roughly 65.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Long Term Investment Analysis - Stock Traders Daily |
Instil Bio Quarterly Long Term Debt |
|
Instil Bio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Instil Bio. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Instil Bio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Instil Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Instil Bio's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-08-14 | 2023-06-30 | -0.16 | -0.14 | 0.02 | 12 | ||
2022-05-16 | 2022-03-31 | -0.38 | -0.42 | -0.04 | 10 | ||
2022-08-12 | 2022-06-30 | -0.41 | -0.46 | -0.05 | 12 | ||
2022-03-07 | 2021-12-31 | -0.36 | -0.43 | -0.07 | 19 | ||
2021-08-12 | 2021-06-30 | -0.2 | -0.27 | -0.07 | 35 | ||
2021-05-13 | 2021-03-31 | -0.52 | -0.66 | -0.14 | 26 | ||
2023-03-31 | 2022-12-31 | -0.41 | -0.24 | 0.17 | 41 | ||
2023-05-11 | 2023-03-31 | -0.15 | -0.44 | -0.29 | 193 |
Know Instil Bio's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Instil Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Instil Bio backward and forwards among themselves. Instil Bio's institutional investor refers to the entity that pools money to purchase Instil Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-03-31 | 34.8 K | Millennium Management Llc | 2024-03-31 | 31.4 K | Two Sigma Advisers, Llc | 2024-03-31 | 29.5 K | Squarepoint Ops Llc | 2024-03-31 | 17.4 K | State Street Corporation | 2024-03-31 | 11.7 K | Acadian Asset Management Llc | 2024-03-31 | 10.2 K | Morgan Stanley - Brokerage Accounts | 2024-03-31 | 5.6 K | Barclays Plc | 2024-03-31 | 479 | Tower Research Capital Llc | 2024-03-31 | 274 | Curative Ventures V Llc | 2023-12-31 | 1.9 M | Vivo Capital, Llc | 2024-03-31 | 624.3 K |
Instil Bio's market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 67.25 M.Market Cap |
|
Instil Bio's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.48) | (0.50) | |
| Return On Capital Employed | (0.29) | (0.30) | |
| Return On Assets | (0.48) | (0.50) | |
| Return On Equity | (0.69) | (0.66) |
Determining Instil Bio's profitability involves analyzing its financial statements and using various financial metrics to determine if Instil Bio is a good buy. For example, gross profit margin measures Instil Bio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Instil Bio's profitability and make more informed investment decisions.
Instil Bio's Earnings Breakdown by Geography
The data published in Instil Bio's official financial statements typically reflect Instil Bio's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Instil Bio's quantitative information. For example, before you start analyzing numbers published by Instil accountants, it’s essential to understand Instil Bio's liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.
Evaluate Instil Bio's management efficiency
Instil Bio has Return on Asset of (0.1301) % which means that on every $100 spent on assets, it lost $0.1301. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.4771) %, meaning that it generated no profit with money invested by stockholders. Instil Bio's management efficiency ratios could be used to measure how well Instil Bio manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.5. The value of Return On Capital Employed is expected to slide to -0.3. At this time, Instil Bio's Total Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 670.4 M this year, although the value of Other Current Assets will most likely fall to about 6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 34.72 | 27.15 | |
| Tangible Book Value Per Share | 34.72 | 26.36 | |
| Enterprise Value Over EBITDA | (1.46) | (1.53) | |
| Price Book Value Ratio | 0.22 | 0.23 | |
| Enterprise Value Multiple | (1.46) | (1.53) | |
| Price Fair Value | 0.22 | 0.23 | |
| Enterprise Value | 143.7 M | 136.5 M |
The analysis of Instil Bio's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Instil Bio's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Instil Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.183 |
Basic technical analysis of Instil Stock
As of the 12th of June 2024, Instil Bio retains the Risk Adjusted Performance of (0.03), market risk adjusted performance of (0.17), and Standard Deviation of 2.27. Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Instil Bio, as well as the relationship between them. Please check out Instil Bio market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Instil Bio is priced fairly, providing market reflects its last-minute price of 10.84 per share. Given that Instil Bio has information ratio of (0.06), we strongly advise you to confirm Instil Bio's regular market performance to make sure the company can sustain itself at a future point.Instil Bio's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Instil Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Instil Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Instil Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Curative Ventures V Llc over three weeks ago Disposition of 1192729 shares by Curative Ventures V Llc of Instil Bio subject to Rule 16b-3 | ||
Curative Ventures V Llc over a month ago Disposition of 1192729 shares by Curative Ventures V Llc of Instil Bio subject to Rule 16b-3 | ||
Curative Ventures V Llc over two months ago Disposition of 5082333 shares by Curative Ventures V Llc of Instil Bio subject to Rule 16b-3 | ||
Laumas Sandeep over three months ago Acquisition by Laumas Sandeep of 80000 shares of Instil Bio subject to Rule 16b-3 |
Understand Instil Bio's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Instil Bio's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.17) | |||
| Mean Deviation | 1.83 | |||
| Coefficient Of Variation | (1,818) | |||
| Standard Deviation | 2.27 | |||
| Variance | 5.15 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.11) | |||
| Treynor Ratio | (0.18) | |||
| Maximum Drawdown | 9.17 | |||
| Value At Risk | (3.28) | |||
| Potential Upside | 4.15 | |||
| Skewness | 0.3898 | |||
| Kurtosis | (0.57) |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.17) | |||
| Mean Deviation | 1.83 | |||
| Coefficient Of Variation | (1,818) | |||
| Standard Deviation | 2.27 | |||
| Variance | 5.15 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.11) | |||
| Treynor Ratio | (0.18) | |||
| Maximum Drawdown | 9.17 | |||
| Value At Risk | (3.28) | |||
| Potential Upside | 4.15 | |||
| Skewness | 0.3898 | |||
| Kurtosis | (0.57) |
Consider Instil Bio's intraday indicators
Instil Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Instil Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Instil Bio Corporate Filings
8K | 10th of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 2nd of April 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 13th of February 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Instil Stock media impact
Far too much social signal, news, headlines, and media speculation about Instil Bio that are available to investors today. That information is available publicly through Instil media outlets and privately through word of mouth or via Instil internal channels. However, regardless of the origin, that massive amount of Instil data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Instil Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Instil Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Instil Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Instil Bio alpha.
Instil Bio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Instil Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Instil Bio Corporate Management
| Sandeep MD | CFO Officer | Profile | |
| Timothy Moore | Chief Officer | Profile | |
| Bronson Crouch | Chairman CEO | Profile | |
| Sumita JD | Compliance, Legal | Profile | |
| Mark Dudley | Chief Officer | Profile | |
| Robert MBBS | Head Development | Profile |
Additional Information and Resources on Investing in Instil Stock
When determining whether Instil Bio is a strong investment it is important to analyze Instil Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instil Bio's future performance. For an informed investment choice regarding Instil Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (18.97) | Return On Assets (0.13) | Return On Equity (0.48) |
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Instil Bio's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.